RTN4 and Cerebral ischemia: Using monoclonal antibodies (mAbs) to neutralize Nogo-A or using soluble fragments of NgR to block the Nogo-A-NgR interaction has been found to increase axonal outgrowth and sprouting significantly, which correlates with an improvement of functional outcome after cerebral ischemia or stroke [22,32,33].